Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosis.
Charles MidolEdgar WiebeElise SiegertDörte HuscherHélène BéhalDavid LaunayEric HachullaEric L MattesonFrank ButtgereitVincent SobanskiPublished in: Rheumatology (Oxford, England) (2024)
Our study shows that OP risk in patients with SSc is determined by age, disease-related factors such as diffuse cutaneous subset, ILD and anti-topoisomerase I antibody positivity, but also treatment with GC independently of other factors.